Kevin Pollack
2013
In 2013, Kevin Pollack earned a total compensation of $1.5M as CFO at OPIANT PHARMACEUTICALS, a 3,572% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,318,500 |
|---|---|
| Salary | $150,260 |
| Total | $1,468,760 |
Pollack received $1.3M in option awards, accounting for 90% of the total pay in 2013.
Pollack also received $150.3K in salary.
Rankings
In 2013, Kevin Pollack's compensation ranked 5,023rd out of 12,286 executives tracked by ExecPay. In other words, Pollack earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,023 out of 12,286 | 59th |
Division Mining | 294 out of 591 | 50th |
Major group Metal Mining | 17 out of 85 | 80th |
Source: SEC filing on September 11, 2014.
Pollack's colleagues
We found two more compensation records of executives who worked with Kevin Pollack at OPIANT PHARMACEUTICALS in 2013.